FOXO1 and metastatic neoplasm: Many studies have identified FOXO1 fusion status as a prognostic factor in RMS and have also reported on the additional impact of clinical factors, but most have analyzed localized and metastatic tumors together and been conducted with convenience cohorts.16, 19, 20, 38, 39